ACM
CMPX icon

Aquatic Capital Management’s Compass Therapeutics CMPX Stock Holding History

Aquatic Capital Management’s Portfolio CMPX Stock Details CMPX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-73,338
Closed -$388K – 1330
2026
Q1 		$388K Buy
+73,338
New +$423K 0.01% 827
2023
Q3 		– Sell
-100
Closed – – 1301
2023
Q2 		$0 Buy
+100
New +$314 ﹤0.01% 1396

Other funds holding CMPX

TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $345M AUM 134.64% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Aquatic Capital Management's CMPX Position: Q2 2026 in Review

Aquatic Capital Management sold out of Compass Therapeutics (CMPX) in Q2 2026, closing a stake of 73,338 shares — an estimated $388K sold.

Aquatic Capital Management first reported a position in CMPX in Q2 2023 and held it in 2 quarters. The position peaked at $388K in Q1 2026. 216 funds tracked by Wall St. Rank hold CMPX as of Q2 2026.

  • Aquatic Capital Management reported no remaining Compass Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Aquatic Capital Management sold 73,338 Compass Therapeutics shares in Q2 2026, an estimated $388K.
  • Aquatic Capital Management first reported a position in Compass Therapeutics in Q2 2023 and held it in 2 quarters.
  • Aquatic Capital Management's Compass Therapeutics position peaked at $388K in Q1 2026.
  • 216 funds tracked by Wall St. Rank held Compass Therapeutics as of Q2 2026.

Based on Aquatic Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.